Covered recipient · General Payments record
LUKE A DONATELLI
Allopathic & Osteopathic Physicians Otolaryngology
General Payments · PY2018–2024
$1,642.96
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $639.85 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $136.76 | 1 |
| OptiNose US, Inc. | $115.56 | 5 |
| GlaxoSmithKline, LLC. | $109.07 | 4 |
| Medtronic, Inc. | $98.52 | 3 |
| Neurent Medical Limited | $82.80 | 1 |
| Hikma Pharmaceuticals USA | $50.50 | 1 |
| PFIZER INC. | $23.45 | 1 |
| Grifols USA, LLC | $23.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GENZYME CORPORATION | $136.76 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139937791 | CMS |
| GlaxoSmithKline, LLC. | $27.37 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116685223 | CMS |
| GlaxoSmithKline, LLC. | $24.62 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116734328 | CMS |
| GlaxoSmithKline, LLC. | $30.31 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116678965 | CMS |
| GlaxoSmithKline, LLC. | $26.77 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116631856 | CMS |
| Grifols USA, LLC | $23.19 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124754746 | CMS |
| Hikma Pharmaceuticals USA | $50.50 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127505050 | CMS |
| Medtronic, Inc. | $25.32 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117078919 | CMS |
| Medtronic, Inc. | $26.22 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117078923 | CMS |
| Medtronic, Inc. | $46.98 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117078921 | CMS |
| Neurent Medical Limited | $82.80 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1098841129 | CMS |
| Optinose US, Inc. | $21.96 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142194672 | CMS |
| Optinose US, Inc. | $23.18 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142194714 | CMS |
| Optinose US, Inc. | $23.19 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142194698 | CMS |
| Optinose US, Inc. | $23.35 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142194724 | CMS |
| Optinose US, Inc. | $23.88 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142194774 | CMS |
| PFIZER INC. | $23.45 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131199433 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.